Sublingual grass allergen specific immunotherapy: a retrospective study of clinical outcome and discontinuation

机译：舌下草过敏原特异性免疫疗法：临床结局和停药的回顾性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundSublingual immunotherapy (SLIT) is effective, tolerable, and convenient for many allergic patients. Still, real-world evidence is scarce and the aim of this study is to assess the patient reported outcome of treatment with SLIT against grass pollen allergy in a consecutive patient population.

机译：背景舌下免疫疗法（SLIT）对于许多变态反应性患者而言是有效，可耐受且方便的。尽管如此，现实世界中的证据仍然很少，并且本研究的目的是评估连续报道的患者中针对SLIT治疗对草粉花粉过敏的患者报道的结果。

著录项

期刊名称 Clinical and Molecular Allergy : CMA
作者
Christer Janson; Fredrik Sundbom; Peter Arvidsson; Mary Kämpe;
展开▼
作者单位

展开▼
年(卷),期 2018(16),-1
年度 2018
页码 14
总页数 8
原文格式 PDF
正文语种
中图分类分子生物学;
关键词
Grass pollen allergy Sublingual immunotherapy SLIT Patient reported outcome Adherence Real-world evidence;

机译：草花粉过敏;舌下免疫疗法;SLIT;患者报告的结局;依从性;真实证据;

相似文献

外文文献
中文文献
专利

1. Sublingual grass allergen specific immunotherapy: a retrospective study of clinical outcome and discontinuation [J] . Christer Janson, Fredrik Sundbom, Peter Arvidsson, Clinical and Molecular Allergy . 2018,第1期

机译：舌下草过敏原特异性免疫疗法：临床结局和停药的回顾性研究
2. Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells. [J] . Scadding GW, Shamji MH, Jacobson MR, Clinical and experimental allergy : . 2010,第4期

机译：舌下草粉花粉免疫疗法与舌下Foxp3表达细胞的增加和过敏原特异性免疫球蛋白G4，免疫球蛋白A的升高以及血清对免疫球蛋白E促进的过敏原与B细胞结合的抑制活性有关。
3. Allergen-specific CD4+ T cell responses in peripheral blood do not predict the early onset of clinical efficacy during grass pollen sublingual immunotherapy [J] . BonvaletM., MoussuH., WambreE., Clinical and experimental allergy : . 2012,第12期

机译：草花粉舌下免疫治疗过程中外周血的过敏原特异性CD4 + T细胞反应不能预测临床疗效的早期发作
4. Allergen specific immunotherapy of respiratory allergy: the clinical outcome [C] . Nikolov G., Michova A., Hristova M., World Asthma and COPD Forum . 2010

机译：呼吸道过敏的过敏原特异性免疫疗法：临床结果
5. Structural, Functional and Immunological Studies of Group 1 and 2 House Dust Mite and Profilin Allergens for the Development of Allergen Specific Diagnostics and Immunotherapy [D] . Kapingidza, Anyway B. 2020

机译：第1族和2次房屋粉尘和毛细血管过敏原特异性诊断和免疫疗法的结构，功能和免疫学研究
6. Allergen Immunotherapy 1: 5 Posttreatment Long-Term Clinical Efficacy of a 300 IR Sublingual Tablet of 5-Grass Pollen Allergen Extract in Adults With Grass Pollen Induced Allergic Rhinoconjunctivitis [O] . Alain Didier, Friedrich Horak, Margitta Worm, 2012

机译：过敏原免疫疗法1：5 5草花粉诱导的过敏性鼻结膜炎成虫的5代草粉花粉过敏原提取物的300 IR舌下片的5后期治疗长期临床疗效
7. Sublingual grass pollen immunotherapy is associated with increases in sublingual Foxp3-expressing cells and elevated allergen-specific immunoglobulin G4, immunoglobulin A and serum inhibitory activity for immunoglobulin E-facilitated allergen binding to B cells [O] . Scadding, G. W., Pilette, Charles, Shamji, M. H., 2010

机译：舌下草粉花粉免疫疗法与舌下Foxp3表达细胞的增加和过敏原特异性免疫球蛋白G4，免疫球蛋白A的升高以及血清对免疫球蛋白E促成的过敏原与B细胞的抑制活性有关

Sublingual grass allergen specific immunotherapy: a retrospective study of clinical outcome and discontinuation

摘要

著录项

相似文献

相关主题

期刊订阅